Isolation of ursolic acid from apple peels and its specific efficacy as a potent antitumor agent

Journal of Health Science

Volumn 54, Issue 6, 2008, Pages 654-660

  Yamaguchi, Hideaki ^a   Noshita, Toshiro ^b   Kidachi, Yumi ^b   Umetsu, Hironori ^c   Hayashi, Masahiko ^d   Komiyama, Kanki ^d   Funayama, Shinji ^e   Ryoyama, Kazuo ^b  

^a MEIJO UNIVERSITY   (Japan)

^b AOMORI UNIVERSITY   (Japan)

^c GIFU SHOTOKU GAKUEN UNIVERSITY   (Japan)

^d KITASATO INSTITUTE   (Japan)

^e NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Apple peels; Cancer; Serum free mouse embryo (SFME); Tumorigenic cells; Ursolic acid

Indexed keywords

AMINOGUANIDINE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR; URSOLIC ACID;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APPLE; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL LINE; CONCENTRATION (PARAMETERS); DRUG EFFICACY; DRUG ISOLATION; EMBRYO CELL; GEL CHROMATOGRAPHY; GROWTH INHIBITION; MOUSE; NONHUMAN;

MALUS X DOMESTICA;

EID: 57349126352     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.54.654     Document Type: Article

References (42)

1. Knekt, P., Jarvinen, R., Seppanen, R., Heliovaara, M., Teppo, L., Pukkala, E. and Aromaa, A. (1997) Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol., 146, 223-230.
2. Eberhardt, M. V., Lee, C. Y. and Liu, R. H. (2000) Antioxidant activity of fresh apples. Nature, 405, 903-904.
3. Le Marchand, L., Murphy, S. P., Hankin, J. H., Wilkens, L. R. and Kolonel, L. N. (2000) Intake of flavonoids and lung cancer. J. Natl. Cancer Inst., 92, 154-160.
4. Ding, M., Lu, Y., Bowman, L., Huang, C., Leonard, S., Wang, L., Vallyathan, V., Castranova, V. and Shi, X. (2004) Inhibition of AP-1 and neoplastic transformation by fresh apple peel extract. J. Biol. Chem., 279, 10670-10676.
5. He, X. and Liu, R. H. (2007) Triterpenoids isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple's anticancer activity. J. Agric. Food Chem., 55, 4366-4370.
6. Wolfe, K., Wu, X. Z. and Liu, R. H. (2003) Antioxidant activity of apple peels. J. Agric. Food Chem., 51, 609-614.
7. Wolfe, K. and Liu, R. H. (2003) Apple peels as a value-added food ingredient. J. Agric. Food Chem., 51, 1676-1683.
8. Suh, N., Honda, T., Finlay, H. J., Barchowsky, A., Williams, C., Benoit, N. E., Xie, Q., Nathan, C., Gribble, G. W. and Sporn, M. B. (1998) Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res., 58, 717-723.
9. Ohigashi, H., Takamura, H., Koshimizu, K., Tokuda, H. and Ito, Y. (1986) Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation; Ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L. Cancer Lett., 30, 143-151.
10. Tokuda, H., Ohigashi, H., Koshimizu, K. and Ito, Y. (1986) Inhibitory effects of ursolic and oleanolic ancid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Lett., 33, 279-285.
11. Huang, M. T., Ho, C. T., Wang, Z. Y., Ferraro, T., Lou, Y. R., Stauber, K., Ma, W., Georgiadis, C., Laskin, J. D. and Conney, A. H. (1994) Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res., 54, 701-708.
12. Young, H. S., Chung, H. Y., Lee, C. K., Park, K. Y., Yokozawa, T. and Oura, H. (1994) Ursolic acid inhibits aflatoxin B1-induced mutagenicity in a Salmonella assay system. Biol. Pharm. Bull., 17, 990-992.
13. Liu, J. (1995) Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol., 49, 57-68.
14. Mahato, S. B., Sarkar, S. K. and Poddar, G. (1988) Triterpenoid saponins. Phytochemistry, 27, 3037-3067.
15. Nishino, H., Nishino, A., Takayasu, J., Hasegawa, T., Iwashima, A., Hirabayashi, K., Iwata, S. and Shibata, S. (1988) Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds. Cancer Res., 48, 5210-5215.
16. Najid, A., Simon, A., Cook, J., Chable-Rabinovitch, H., Delage, C., Chulia, A. J. and Rigaud, M. (1992) Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS Lett., 299, 213-217.
17. Manez, S., Recio, M. C., Giner, R. M. and Rios, J. L. (1997) Effect of selected triterpenoids on chronic dermal inflammation. Eur. J. Pharmacol., 334, 103-105.
18. 2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int. J. Cancer, 73, 725-728.
19. Lauthier, F., Taillet, L., Trouillas, P., Delage, C. and Simon, A. (2000) Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells. Anticancer Drugs, 11, 737-745.
20. Lee, H. Y., Chung, H. Y., Kim, K. H., Lee, J. J. and Kim, K. W. (1994) Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. J. Cancer Res. Clin. Oncol., 120, 513-518.
21. Sohn, K. H., Lee, H. Y., Chung, H. Y., Young, H. S., Yi, S. Y. and Kim, K. W. (1995) Anti-angiogenic activity of triterpene acids. Cancer Lett., 94, 213-218.
22. Cha, H. J., Bae, S. K., Lee, H. Y., Lee, O. H., Sato, H., Seiki, M., Park, B. C. and Kim, K. W. (1996) Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res., 56, 2281-2284.
23. Loo, D. T., Fuquay, J. I., Rawson, C. L. and Barnes, D. W. (1987) Extended culture of mouse embryo cells without senescence: inhibition by serum. Science, 236, 200-202.
24. Loo, D., Rawson, C., Helmrich, A. and Barnes, D. (1989) Serum-free mouse embryo (SFME) cells: growth responses in vitro. J. Cell. Physiol., 139, 484-491.
25. Rawson, C., Cosola-Smith, C. and Barnes, D. (1990) Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation is prevented by cycloheximide, 12-O-tetradecanoylphorbol-13-acetate, or vanadate. Exp. Cell Res., 186, 177-181.
26. Rawson, C., Shirahata, S., Collodi, P., Natsuno, T. and Barnes, D. (1991) Oncogene transformation frequency of nonsenescent SFME cells is increased by c-myc. Oncogene, 6, 487-489.
27. Nomura, T., Matano, S., Okada, G., Tokuyama, H., Hori, I., Nakamura, S., Kameyama, T. and Ryoyama, K. (1993) Establishment of a metastatic murine cell line carrying the human c-Ha-ras. In Vitro Cell. Dev. Biol., 29A, 614-616.
28. Ham, R. G. and McKeehan, W. L. (1979) Media and growth requirements. Methods Enzymol., 58, 44-93.
29. Mather, J. P. and Sato, G. H. (1979) The use of hormone-supplemented serum-free media in primary cultures. Exp. Cell Res., 124, 215-221.
30. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D. and Mitchell, J. B. (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res., 47, 943-946.
31. Aggarwal, B. B., Schwarz, L., Hogan, M. E. and Rando, R. F. (1996) Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Res., 56, 5156-5164.
32. Giri, D. K. and Aggarwal, B. B. (1998) Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J. Biol. Chem., 273, 14008-14014.
33. You, H. J., Choi, C. Y., Kim, J. Y., Park, S. J., Hahm, K. S. and Jeong, H. G. (2001) Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages. FEBS Lett., 509, 156-160.
34. Ryoyama, K. (1992) Effector molecules from antitumor macrophages induced with OK-432 and cyclophosphamide. Cancer Immunol. Immunother., 35, 7-13.
35. Dong, Z., Staroselsky, A. H., Qi, X., Xie, K. and Fidler, I. J. (1994) Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res., 54, 789-793.
36. Xie, K., Huang, S., Dong, Z., Juang, S. H., Gutman, M., Xie, Q. W., Nathan, C. and Fidler, I. J. (1995) Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med., 181, 1333-1343.
37. Juang, S. H., Xie, K., Xu, L., Shi, Q., Wang, Y., Yoneda, J. and Fidler, I. J. (1998) Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum. Gene Ther., 9, 845-854.
38. Edwards, P., Cendan, J. C., Topping, D. B., Moldawer, L. L., MacKay, S., Copeland, E. M., IIIrd and Lind, D. S. (1996) Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J. Surg. Res., 63, 49-52.
39. Shi, Q., Xiong, Q., Wang, B., Le, X., Khan, N. A. and Xie, K. (2000) Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis. Cancer Res., 60, 2579-2583.
40. Gallo, O., Masini, E., Morbidelli, L., Franchi, A., Fini-Storchi, I., Vergari, W. A. and Ziche, M. (1998) Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer Inst., 90, 587-596.
41. Xie, K. and Fidler, I. J. (1998) Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev., 17, 55-75.
42. Liao, Q., Yang, W., Jia, Y., Chen, X., Gao, Q. and Bi, K. (2005) LC-MS detection and pharmacokinetic studies of ursolic acid in rat plasma after administration of the traditional Chinese medicinal preparation Lu-Ying extract. Yakugaku Zasshi, 125, 509-515.